Home › Epithelial Carcinoma ng Ovary
Pag-aaral pangklinika para sa Epithelial Carcinoma ng Ovary na nagre-recruit sa U.S.
26 pag-aaral para sa Epithelial Carcinoma ng Ovary ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA9 pag-aaral
- Durham, NC8 pag-aaral
- San Diego, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- New York City, NY7 pag-aaral
- Houston, TX6 pag-aaral
- Philadelphia, PA6 pag-aaral
- Los Angeles, CA5 pag-aaral
- Edison, NJ5 pag-aaral
- Salt Lake City, UT5 pag-aaral
- Portland, OR5 pag-aaral
- Cleveland, OH5 pag-aaral
- Baltimore, MD5 pag-aaral
- Minneapolis, MN5 pag-aaral
- Seattle, WA4 pag-aaral
- Queens, NY4 pag-aaral
- Arlington, VA4 pag-aaral
- Dallas, TX4 pag-aaral
- New Haven, CT4 pag-aaral
- St. Louis, MO4 pag-aaral
- Birmingham, AL4 pag-aaral
- San Antonio, TX4 pag-aaral
- Oklahoma City, OK3 pag-aaral
- San Francisco, CA3 pag-aaral
- Aurora, CO3 pag-aaral
- Mountain View, CA3 pag-aaral
- Clifton, NJ3 pag-aaral
- Shreveport, LA3 pag-aaral
- West Palm Beach, FL3 pag-aaral
- Dayton, OH3 pag-aaral
- Grand Rapids, MI3 pag-aaral
- Nashville, TN3 pag-aaral
- Indianapolis, IN3 pag-aaral
- Sioux Falls, SD3 pag-aaral
- Providence, RI3 pag-aaral
- Columbus, OH3 pag-aaral
- Rochester, MN3 pag-aaral
- New Orleans, LA3 pag-aaral
- Washington, DC3 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- Arizona4 pag-aaral
- California10 pag-aaral
- Colorado4 pag-aaral
- Connecticut4 pag-aaral
- Florida10 pag-aaral
- Georgia3 pag-aaral
- Illinois8 pag-aaral
- Indiana3 pag-aaral
- Louisiana4 pag-aaral
- Maryland6 pag-aaral
- Massachusetts10 pag-aaral
- Michigan5 pag-aaral
- Minnesota7 pag-aaral
- Missouri5 pag-aaral
- New Jersey9 pag-aaral
- New York10 pag-aaral
- North Carolina9 pag-aaral
- Ohio9 pag-aaral
- Oklahoma3 pag-aaral
- Oregon6 pag-aaral
- Pennsylvania10 pag-aaral
- Rhode Island3 pag-aaral
- South Dakota3 pag-aaral
- Tennessee6 pag-aaral
- Texas12 pag-aaral
- Utah5 pag-aaral
- Virginia6 pag-aaral
- Washington6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 15, 2026 · NCT06915025A Study of Isoquercetin in People With Ovarian Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07303894ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Ago 17, 2026 · NCT07764133Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Ago 6, 2026 · NCT06386887AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 21, 2026 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 2, 2026 · NCT06819007A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Hul 1, 2026 · NCT05429970[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Nagre-recruitPhase 1/2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07432633CT-95 in Advanced Cancers Associated With Mesothelin Expression
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06756035Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update May 19, 2026 · NCT06305299Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT05297734A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Abr 7, 2026 · NCT04516447A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Peb 3, 2026 · NCT06469281CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Dis 23, 2025 · NCT06690775Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 30 pataas · Kababaihan · Na-update Set 16, 2025 · NCT04794322A Study of NX-1607 in Adults With Advanced Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 15, 2025 · NCT04429542Genetic Testing Decision Aid
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2025 · NCT05470920A Beta-only IL-2 ImmunoTherapY Study
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 7, 2025 · NCT04196257Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 80 · Kababaihan · Na-update Peb 28, 2025 · NCT00005095Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.